Article ID | Journal | Published Year | Pages | File Type |
---|---|---|---|---|
6184143 | Gynecologic Oncology | 2015 | 26 Pages |
Abstract
Oral progestin is an effective fertility-sparing treatment for women with CAH/G1EC in China. Patients with elevated HbA1C receiving both metformin and progestin were more likely to achieve CR, whereas those with PCOS were not. ART is a good choice for clinical pregnancy after treatment.
Keywords
Related Topics
Health Sciences
Medicine and Dentistry
Obstetrics, Gynecology and Women's Health
Authors
Zhou Rong, Yang Yuan, Lu Qun, Wang Jianliu, Miao Yali, Wang Shijun, Wang Zhiqi, Zhao Chao, Wei Lihui,